• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体4缺陷小鼠对慢性缺氧诱导的肺动脉高压具有抗性。

Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension.

作者信息

Young Karen C, Hussein Sameh M A, Dadiz Rita, deMello Daphne, Devia Carlos, Hehre Dorothy, Suguihara Cleide

机构信息

Department of Pediatrics/Division of Neonatology and Batchelor Children's Research Institute, University of Miami, Miller School of Medicine, Miami, FL 33101, USA.

出版信息

Exp Lung Res. 2010 Mar;36(2):111-9. doi: 10.3109/01902140903171610.

DOI:10.3109/01902140903171610
PMID:20205596
Abstract

Current data suggest that Toll-like receptor 4 (TLR4), a key molecule in the innate immune response, may also be activated following tissue injury. Activation of this receptor is known to induce the production of several proinflammatory cytokines. Given that pulmonary inflammation has been shown to be a key contributor to chronic hypoxia-induced pulmonary vascular remodeling, the authors hypothesized that TLR4-deficient mice would be less susceptible to pulmonary hypertension (PH) as compared to mice with intact TLR4. TLR4-deficient and TLR4-intact strains of inbred mice were exposed to 4, 8, and 16 weeks of hypoxia (0.10 FiO(2)) or normoxia (0.21 FiO(2)) in a normobaric chamber. After chronic hypoxic exposure, TLR4-intact mice developed significant PH evidenced by increased right ventricular systolic pressure, right ventricular hypertrophy, and pulmonary artery medial thickening. In contrast, TLR4-deficient mice had no significant change in any of these parameters and this was associated with decreased pulmonary vascular inflammatory response as compared to the TLR4-intact mice. These results suggest that TLR4 deficiency may decrease the susceptibility to developing PH by attenuating the pulmonary vascular inflammatory response to chronic hypoxia.

摘要

目前的数据表明,Toll样受体4(TLR4)作为先天性免疫反应中的关键分子,在组织损伤后也可能被激活。已知该受体的激活会诱导多种促炎细胞因子的产生。鉴于肺部炎症已被证明是慢性缺氧诱导的肺血管重塑的关键因素,作者推测与TLR4完整的小鼠相比,TLR4缺陷型小鼠对肺动脉高压(PH)的易感性较低。将TLR4缺陷型和TLR4完整型近交系小鼠置于常压低氧舱中,分别暴露于4周、8周和16周的低氧环境(FiO₂为0.10)或常氧环境(FiO₂为0.21)。经过慢性低氧暴露后,TLR4完整型小鼠出现了明显的肺动脉高压,表现为右心室收缩压升高、右心室肥厚和肺动脉中层增厚。相比之下,TLR4缺陷型小鼠在这些参数上均无显著变化,并且与TLR4完整型小鼠相比,其肺血管炎症反应有所减轻。这些结果表明,TLR4缺陷可能通过减弱对慢性缺氧的肺血管炎症反应来降低发生肺动脉高压的易感性。

相似文献

1
Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension.Toll样受体4缺陷小鼠对慢性缺氧诱导的肺动脉高压具有抗性。
Exp Lung Res. 2010 Mar;36(2):111-9. doi: 10.3109/01902140903171610.
2
Critical role of toll-like receptor 4 in hypoxia-inducible factor 1α activation during trauma/hemorrhagic shocky induced acute lung injury after lymph infusion in mice.Toll样受体4在小鼠创伤/失血性休克诱导的急性肺损伤淋巴管输注后缺氧诱导因子1α激活中的关键作用。
Shock. 2014 Sep;42(3):271-8. doi: 10.1097/SHK.0000000000000212.
3
Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.尿激酶型纤溶酶原激活物介导的纤溶酶生成缺陷会损害小鼠缺氧诱导的肺动脉高压期间的血管重塑。
Circulation. 2001 Apr 17;103(15):2014-20. doi: 10.1161/01.cir.103.15.2014.
4
Dissociation of pulmonary vascular remodeling and right ventricular pressure in tissue angiotensin-converting enzyme-deficient mice under conditions of chronic alveolar hypoxia.慢性肺泡缺氧条件下组织血管紧张素转换酶缺陷小鼠肺血管重塑与右心室压力的解离
Am J Respir Crit Care Med. 2001 Apr;163(5):1241-5. doi: 10.1164/ajrccm.163.5.2003144.
5
Hypoxia-inducible factor-1 α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension.髓系谱系中缺氧诱导因子-1α缺失可减轻缺氧诱导的肺动脉高压。
Physiol Rep. 2019 Apr;7(7):e14025. doi: 10.14814/phy2.14025.
6
High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4.高迁移率族蛋白 B1 通过激活 Toll 样受体 4 促进实验性肺动脉高压的发病机制。
Mol Med. 2013 Feb 8;18(1):1509-18. doi: 10.2119/molmed.2012.00283.
7
Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.可溶性鸟苷酸环化酶α1缺乏选择性抑制肺血管对一氧化氮的舒张反应,并增强肺血管对慢性低氧的重塑反应。
Circulation. 2007 Aug 21;116(8):936-43. doi: 10.1161/CIRCULATIONAHA.106.677245. Epub 2007 Aug 6.
8
Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.转化生长因子-β受体的显性负性突变可阻断缺氧诱导的肺血管重塑。
J Appl Physiol (1985). 2006 Feb;100(2):564-71. doi: 10.1152/japplphysiol.00595.2005. Epub 2005 Oct 13.
9
p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice.p53 基因缺失促进低氧诱导的肺动脉高压和小鼠血管重构。
Am J Physiol Lung Cell Mol Physiol. 2011 May;300(5):L753-61. doi: 10.1152/ajplung.00286.2010. Epub 2011 Feb 18.
10
Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.血管抑素在肺部的过表达会加重慢性缺氧小鼠的肺动脉高压。
Am J Respir Cell Mol Biol. 2003 Oct;29(4):449-57. doi: 10.1165/rcmb.2002-0120OC. Epub 2003 Apr 24.

引用本文的文献

1
Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.肝旁路在病原体相关肺血管疾病发展中的作用:中腔静脉分流和门体分流的影响
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G791-G800. doi: 10.1152/ajpgi.00409.2024. Epub 2025 May 5.
2
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series).肺血管疾病的精准医学:未来已来(2023年格罗弗会议系列)
Pulm Circ. 2025 Jan 2;15(1):e70027. doi: 10.1002/pul2.70027. eCollection 2025 Jan.
3
Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
血吸虫病相关肺动脉高压揭示了受损的鼠类肠道-肺部微生物组和减少的内保护性 Cav-1/BMPR2 表达。
Front Immunol. 2023 Oct 16;14:1254762. doi: 10.3389/fimmu.2023.1254762. eCollection 2023.
4
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension.肠道微生物群在肺动脉高压中的作用和机制。
Nutrients. 2022 Oct 13;14(20):4278. doi: 10.3390/nu14204278.
5
TLR4-SIRT3 Mechanism Modulates Mitochondrial and Redox Homeostasis and Promotes EPCs Recruitment and Survival.TLR4-SIRT3 机制调节线粒体和氧化还原稳态,促进 EPCs 的募集和存活。
Oxid Med Cell Longev. 2022 Jul 4;2022:1282362. doi: 10.1155/2022/1282362. eCollection 2022.
6
Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension.肺动脉高压中内皮功能障碍和炎症的表观遗传调控。
Int J Mol Sci. 2021 Nov 9;22(22):12098. doi: 10.3390/ijms222212098.
7
Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb.内皮细胞外烟酰胺磷酸核糖转移酶驱动内皮-间充质转化和临床前肺动脉高压:用一种抗eNAMPT单克隆抗体进行挽救
Pulm Circ. 2021 Nov 12;11(4):20458940211059712. doi: 10.1177/20458940211059712. eCollection 2021 Oct-Dec.
8
Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.氧化还原调节、氧化应激与 3 型肺动脉高压中的炎症
Adv Exp Med Biol. 2021;1303:209-241. doi: 10.1007/978-3-030-63046-1_13.
9
Portopulmonary Hypertension: From Bench to Bedside.门肺高压:从实验台到病床边
Front Med (Lausanne). 2020 Nov 3;7:569413. doi: 10.3389/fmed.2020.569413. eCollection 2020.
10
Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.营养不良、产后生长发育不良、肠道菌群失调与发育中的肺
J Perinatol. 2021 Aug;41(8):1797-1810. doi: 10.1038/s41372-020-00858-x. Epub 2020 Oct 14.